NCT05107674 2025-09-09A Study of NX-1607 in Adults With Advanced MalignanciesNurix Therapeutics, Inc.Phase 1 Recruiting345 enrolled
NCT02419495 2025-06-04Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesM.D. Anderson Cancer CenterPhase 1 Terminated221 enrolled
NCT04602117 2023-11-18ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic CancerQuantumLeap Healthcare CollaborativePhase 1 Withdrawn
NCT02071862 2022-07-20Study of the Glutaminase Inhibitor CB-839 in Solid TumorsCalithera Biosciences, IncPhase 1 Completed210 enrolled